Download PDF
Nervenheilkunde 2011; 30(11): 10
DOI: 10.1055/s-0038-1628453
Übersichtsartikel
Schattauer GmbH

Zytokinproduktion

J. Schönherr
Further Information

Publication History

Publication Date:
22 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C. et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922.
    CrossrefPubMedGoogle Scholar
  • 2 Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M. et al. Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243-65.
    Google Scholar
  • 3 Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981; 01: 1017-21.
    Google Scholar
  • 4 Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull 2002; 25: 1600-3.
    CrossrefPubMedGoogle Scholar
  • 5 Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008; 181: 5396-404.
    CrossrefPubMedGoogle Scholar
  • 6 Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 09: 46-56.
    CrossrefPubMedGoogle Scholar
  • 7 Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13: 16-34.
    CrossrefPubMedGoogle Scholar
  • 8 Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 2010; 18: 172-6.
    CrossrefPubMedGoogle Scholar
  • 9 Hamelryck TW, Dao-Thi MH, Poortmans F, Chrispeels MJ, Wyns L, Loris R. The crystallographic structure of phytohemagglutinin-L. J Biol Chem 1996; 271: 20479-85.
    CrossrefPubMedGoogle Scholar
  • 10 Himmerich H, Fulda S, Sheldrick AJ, Plümäkers B, Rink L. IFN-gamma reduction by tricyclic antidepressants. Int J Psychiatry Med 2010; 40: 413-24.
    CrossrefPubMedGoogle Scholar
  • 11 Himmerich H. et al. Regulatory T cells increased while IL-1 decreased during antidepressant therapy. J Psychiatr Res 2010; 44: 1052-7.
    CrossrefPubMedGoogle Scholar
  • 12 Himmerich H, Schönherr J, Fulda S, Sheldrick AJ, Bauer K, Sack U. Impact of antipsychotics on cytokine production in-vitro. aJ Psychiatr Res. 2011 Epub ahead of print.
    PubMedGoogle Scholar
  • 13 Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 05: 401-12.
    CrossrefPubMedGoogle Scholar
  • 14 Kim J, Urban RG, Strominger JL. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994; 266: 1870-4.
    CrossrefPubMedGoogle Scholar
  • 15 Kirchner H, Kleinicke C, Digel W. A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982; 48: 213-9.
    CrossrefPubMedGoogle Scholar
  • 16 Kubera M, Kenis G, Bosmans E, Kajta M, BastaKaim A, Scharpe S. et al. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 2004; 04: 185-92.
    CrossrefPubMedGoogle Scholar
  • 17 Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol 2010; 07: 182-9.
    CrossrefPubMedGoogle Scholar
  • 18 Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol 2006; 33: 519-24.
    CrossrefPubMedGoogle Scholar
  • 19 Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL. et al. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection. Clin Transplant 2003; 17: 69-74.
    PubMedGoogle Scholar
  • 20 Miller DB, O’Callaghan JP. Depression, cytokines, and glial function. Metabolism 2005; 54: 33-8.
    PubMedGoogle Scholar
  • 21 Mutschler E, Geisslinger G, Kroemer HK, SchäferKorting M. Arzneimittelwirkungen. 8. Aufl. Stutt- gart: Wissenschaftliche Verlagsgesellschaft 2001; 937.
    Google Scholar
  • 22 Pickering M, Cumiskey D, O’Conner JJ. Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005; 90: 663-70.
    CrossrefPubMedGoogle Scholar
  • 23 Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H. et al. Pro-inflammatory biomakers in depression: Treatment with venlafaxine. World J Biol Psychiatry 2008; 31: 1-11.
    Google Scholar
  • 24 Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-17.
    CrossrefPubMedGoogle Scholar
  • 25 Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 1995; 41: 534-8.
    CrossrefPubMedGoogle Scholar
  • 26 Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH. et al. A detailed examination of cytokine abnormalities in major depressive disorder. European Neuropsychopharmacology 2008; 18: 230-3.
    CrossrefPubMedGoogle Scholar
  • 27 Stølevik SB, Nygaard UC, Namork E, Granum B, Pellerud A, van Leeuwen DM. et al. In vitro cytokine release from human peripheral blood mononuclear cells in the assessment of the immunotoxic potential of chemicals. Toxicol In Vitro 2011; 25: 555-62.
    CrossrefPubMedGoogle Scholar
  • 28 Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A. et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29-35.
    CrossrefPubMedGoogle Scholar
  • 29 Wagner-Jauregg J. Über die Einwirkung fieberhafter Erkrankungen auf Psychosen. JB Psychiatr 1887; a7: 94-131.
    Google Scholar
  • 30 Whitrow M. Julius Wagner-Jauregg (1857–1940). J Med Biogr 1993; 01: 137-43.
    CrossrefPubMedGoogle Scholar
  • 31 Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006; 31: 2121-31.
    CrossrefPubMedGoogle Scholar